PSA response signatures – a powerful new prognostic indicator after radiation for prostate cancer?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PSA response signatures – a powerful new prognostic indicator after radiation for prostate cancer?

Published:2009-03 Issue:3 Volume:90 Page:382-388
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Denham James W.,Lamb David S.,Joseph David,Matthews John,Atkinson Chris,Spry Nigel A.,Duchesne Gillian,Ebert Martin,Steigler Allison,D’Este Catherine

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference31 articles.

1. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy;Pollack;Int J Radiat Oncol Biol Phys,2003

2. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

3. Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer;Zelefsky;J Clin Oncol,2005

4. Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death;Alcantara;Cancer,2007

5. Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy;Buyyounouski;Int J Radiat Oncol Biol Phys,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Treatment Outcomes of Prostate Cancer Patients With Lymph Node Metastasis Treated With Definitive Radiotherapy;Clinical Nuclear Medicine;2024-05-31

2. Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer;Radiotherapy and Oncology;2022-04

3. Prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancer;Brachytherapy;2017-09

4. Suivi après radiothérapie des cancers de prostate : évaluation et prise en charge de la toxicité et de la récidive;Cancer/Radiothérapie;2015-10

5. Time to Nadir PSA;American Journal of Clinical Oncology;2015-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3